Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morito Endo

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Cellular Physiology|May 24, 2007
Complement 3 is involved in changing the phenotype of human glomerular mesangial cellsJian-Xin Wan, Noboru Fukuda, Morito Endo, et al.
Nephron. Clinical Practice|November 12, 2005
Serum mannose-binding lectin levels in maintenance hemodialysis patients: impact on all-cause mortalityAtsushi Satomura, Morito Endo, Takayuki Fujita, et al.
Hypertension (Dallas, Tex. : 1979)|May 12, 2004
Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive ratsZhi-Hong Lin, Noboru Fukuda, Xue-Qing Jin, et al.
Anticancer Research|June 4, 2021
COMMD5 Inhibits Malignant Behavior of Renal Cancer CellsJin Ikeda, Hiroyuki Matsuda, Maiko Ogasawara, et al.
American Journal of Physiology. Renal Physiology|August 9, 2013
Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in miceXueli Zhou, Noboru Fukuda, Hiroyuki Matsuda, et al.
American Journal of Physiology. Renal Physiology|September 27, 2018
Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive ratsEriko Negishi, Noboru Fukuda, Tomoyasu Otsuki, et al.
Stem Cell Research & Therapy|April 19, 2015
Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6Takashi Maruyama, Noboru Fukuda, Taro Matsumoto, et al.
Oncotarget|October 21, 2017
HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinomaHiroyuki Matsuda, Carole G Campion, Kyoko Fujiwara, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Cellular Physiology|May 24, 2007
Complement 3 is involved in changing the phenotype of human glomerular mesangial cellsJian-Xin Wan, Noboru Fukuda, Morito Endo, et al.
Nephron. Clinical Practice|November 12, 2005
Serum mannose-binding lectin levels in maintenance hemodialysis patients: impact on all-cause mortalityAtsushi Satomura, Morito Endo, Takayuki Fujita, et al.
Hypertension (Dallas, Tex. : 1979)|May 12, 2004
Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive ratsZhi-Hong Lin, Noboru Fukuda, Xue-Qing Jin, et al.
Anticancer Research|June 4, 2021
COMMD5 Inhibits Malignant Behavior of Renal Cancer CellsJin Ikeda, Hiroyuki Matsuda, Maiko Ogasawara, et al.
American Journal of Physiology. Renal Physiology|August 9, 2013
Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in miceXueli Zhou, Noboru Fukuda, Hiroyuki Matsuda, et al.
American Journal of Physiology. Renal Physiology|September 27, 2018
Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive ratsEriko Negishi, Noboru Fukuda, Tomoyasu Otsuki, et al.
Stem Cell Research & Therapy|April 19, 2015
Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6Takashi Maruyama, Noboru Fukuda, Taro Matsumoto, et al.
Oncotarget|October 21, 2017
HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinomaHiroyuki Matsuda, Carole G Campion, Kyoko Fujiwara, et al.
Pageof 4